BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  Silexion Therapeutics Reports Groundbreaking Positive Initial Data from Systemic Administration of SIL204 in Orthotopic Pancreatic Cancer Models

  March 5, 2025

   · 

  6 min read
• Press Releases

  Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance

  March 5, 2025

   · 

  11 min read
• Press Releases

  Wiley appoints Karen N. Madden, Ph.D., to its Board of Directors

  March 5, 2025

   · 

  4 min read
• Press Releases

  Longeveron® to Present at the 37th Annual Roth Conference

  March 5, 2025

   · 

  1 min read
• Press Releases

  ITF Therapeutics LLC Announces Opening of New U.S. Headquarters in Concord, Massachusetts

  March 5, 2025

   · 

  6 min read
• Press Releases

  Phio Pharmaceuticals Announces Completion of Enrollment in Third Safety Cohort in PH-762 Phase 1b Dose-Escalation Study

  March 5, 2025

   · 

  4 min read
• Press Releases

  Ascend Advanced Therapies Appoints John Chiminski as Chair and Karen Flynn as Independent Director

  March 5, 2025

   · 

  3 min read
• Press Releases

  Anova Announces First Patient Enrolled to Phase 1/2a Study of DB107 for the Treatment of High-Grade Gliomas

  March 5, 2025

   · 

  5 min read
• Press Releases

  ARS Pharmaceuticals Announces FDA Approval of neffy® 1 mg (epinephrine nasal spray) for Type I Allergic Reactions, Including Anaphylaxis, in Pediatric Patients Weighing 15 to < 30 Kilograms

  March 5, 2025

   · 

  11 min read
• Press Releases

  Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial Guidance

  March 5, 2025

   · 

  19 min read